Navigation Links
Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
Date:8/9/2012

edicine by helping oncologists to select the right drugs for the right patients at the right time.

"With the continued support of the NCI through the SBIR program, Pharmatech Oncology is now positioned to advance this innovative approach in partnership with the other stakeholders in cancer research: the trial sponsors, research and advocacy organizations, the hematology-oncology professional community, and most of all cancer patients," said Dr. Wiener. "We want every cancer patient to have the best treatment options, including these advanced clinical trials."

About Pharmatech Oncology, Inc.:

Pharmatech Oncology, headquartered in Denver, Colorado, is a Contract Research Organization (CRO) that specializes in creating efficiency in cancer clinical trials. We provide a patient centered approach for the investigational treatment of cancer by organizing and directing the entire research process, from start to finish.

For more information about Pharmatech, please visit www.pharmatechoncology.com.

The project described is supported by Award Number R44CA144362 from the National Cancer institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.


'/>"/>
SOURCE Pharmatech Oncology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. WuXi PharmaTech Announces First-Quarter 2012 Results
2. Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Champions Oncology Reports Resignation Of Director
5. Center for Medicare & Medicaid Innovation Awards $19 Million Grant to Develop Oncology Medical Home Model
6. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
7. Radiation Therapy in Oncology Drug Pipeline Update 2012
8. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
9. Schulman Associates IRB offers oncology-focused review board
10. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
11. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... PALO ALTO, Calif. , Sept. 30, 2014 ... early-stage investment group focused on supporting promising emerging ... companies, has been named the Top Angel Investment ... CB Insights as the best performer out of ... that included: historical performance, network strength (connections), selection ...
(Date:9/30/2014)... DIEGO , Sept. 30, 2014 ... three-dimensional biology company focused on delivering breakthrough 3D ... Liver Model has been selected as a finalist in ... 2014 Most Innovative New Product Awards, sponsored by ... of innovative technology and life sciences products in ...
(Date:9/30/2014)... Inc. ( www.synapsebiomedical.com ) announced today it has ... its NeuRx DPS® System for ALS patients.  The ... requirement was implanted over a month and a ... is the only medical device approved by the ... device that obtained approval at the end of ...
Breaking Medicine Technology:Life Science Angels Ranked the Top Angel Investment Group in the U.S. 2Life Science Angels Ranked the Top Angel Investment Group in the U.S. 3Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 2Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 3
... RYE, N.Y., Oct. 14 Curemark, LLC, a drug research ... announced that it has enrolled the first patients in Phase ... first clinical trial patients have been enrolled at Lake Mary ... sites with a total 170 children across the country. , ...
... Cardiva Medical, Inc. announces today that its President, Glenn ... Chief Executive Officer at Innovative Energy, Inc., an alternative energy ... Medical stated, "I would like to thank Glenn for his ... his tenure as President, we have transformed Cardiva from an ...
Cached Medicine Technology:Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment 2Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc. 2Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc. 3
(Date:9/30/2014)... AutoTex PINK proudly offers pink ... in support of breast cancer awareness and research in ... non-profits to “go pink” -- supporting walks, runs and ... a woman-owned company that is among the nation’s leading ... partnering with their customers to raise breast cancer awareness ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Teeth replacement ... Dental Art Institute in Oxnard and Thousand Oaks, Calif., ... and tomorrow to provide training on full mouth rehabilitation. ... work, placing implants, providing cosmetic dentistry, correcting bite issues, ... said. , Dr. Jivraj, who has traveled to India ...
(Date:9/30/2014)... September 30, 2014 Loffler Companies, ... business technology and services was recognized by BEI ... Effectiveness (FCE) in 2013. This prestigious rating means ... first time and for an extended period following, ... than 20 years BEI Services has been the ...
(Date:9/30/2014)... In honor of National Breast Cancer Awareness ... courageous battles, Incredible Veins, Body & Skin is offering ... Cynosure. , “For cancer patients who receive radiation ... on their skin to accurately aim the radiation on ... survivors, they decide to have their tattoo removed as ...
(Date:9/30/2014)... 30, 2014 Julie Kuriakose, ... Allergy , will discuss how restaurants can become more ... special dietary restrictions at the 2014 Allergy Eats ... Professionals, October 21 in New York City. , “I’m ... topic to such an engaged industry audience. As food ...
Breaking Medicine News(10 mins):Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 2Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 3Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 2Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 3Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 4Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 5Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 2Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 3Health News:Incredible Veins, Body & Skin Takes A Stand Against Breast Cancer With PicoSure® By Cynosure 2Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 2Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 3
... Children,s Health Fund (CHF) strongly supports the health ... its steadfast commitment to this momentous effort.  We believe that ... especially for children.  The action taken shows an unprecedented effort ... well-being of all children in this country.  CHF thanks House ...
... ) today announced it will participate in the Barclays Capital 2010 High Yield Bond and Syndicated Loan Conference in Phoenix, Ariz. , on March 24-26, 2010 . , ... , ... ... ...
... Living wills and surrogate decision makers account for only ... making medical decisions for hospitalized patients lacking the capability to ... Researchers who queried 281 physicians report their conclusions ... of the Journal of the American Geriatrics Society . ...
... AF Stat a collaboration of healthcare leaders ... of people affected by atrial fibrillation (AFib) today ... widget to help healthcare practitioners better explain the risks ... The most common form of heart arrhythmia, AFib affects ...
... , ... the launch of Website Realizer, an efficient solution to reduce the costs for building a ... looking website without writing a single line of code. , ... (PRWEB) March 22, 2010 -- Adritech Software has announced the ...
... fewer irritants than lighter brews, researchers find , ... coffee-lovers with delicate stomachs, scientists may have found a ... gastrointestinal discomfort. , European researchers studying stomach-irritating chemicals in ... production in the stomach. , "The major import of ...
Cached Medicine News:Health News:Statement by Irwin Redlener, MD, President, Children's Health Fund on Passage of a Health Care Reform Package by the House 2Health News:Statement by Irwin Redlener, MD, President, Children's Health Fund on Passage of a Health Care Reform Package by the House 3Health News:HealthSouth To Present at Barclays Capital 2010 High Yield Bond and Syndicated Loan Conference 2Health News:HealthSouth To Present at Barclays Capital 2010 High Yield Bond and Syndicated Loan Conference 3Health News:Numerous factors weighed when patients cannot make their own decisions 2Health News:'AFib Educator' app and widget offers patient dialogue tool for complex cardiovascular disease 2Health News:Adritech Software Releases Website Realizer, a Website Builder to Create Websites without Any Programming Knowledge 2Health News:Coming Soon: A Low-Heartburn Coffee? 2Health News:Coming Soon: A Low-Heartburn Coffee? 3
The WatchMate ID model displays multiple alarms locally with resident ID numbers and this information, along with residents names, can be displayed at a central station. Alarms may be cleared locall...
... Radianse indoor positioning ... measure of where and ... patients flow through care ... data provides intelligence that ...
... supports patient safety by providing patient ... patients are in the right place ... the exact patient location when a ... Measure patient flow times to identify ...
... VACUETTE Blood Collection Needles are preominantly used ... for single-use. The colour of the needle ... individual needle gauges. For example, yellow symbolises ... green 21 G (0.80 mm) and black ...
Medicine Products: